Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dermopathy and peripheral neuropathy]

Bernardino Roca1

  • 1Unidad de Enfermedades Infecciosas, Hospital General de Castellón, Castellón de la Plana, Spain. brocav@meditex.es

Enfermedades Infecciosas Y Microbiologia Clinica
|December 6, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort.

Infectious diseases and therapy·2022
Same author

Epidemiological and clinical characteristics of HIV infection in the Spanish VACH Cohort: a descriptive study.

Epidemiologia e prevenzione·2022
Same author

Assessment of Drug Interactions with Online Electronic Checkers in Multi-Pathological Patients.

Pharmacology·2021
Same author

eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort.

HIV research & clinical practice·2021
Same author

Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.

PloS one·2021
Same author

Factors Associated with Nonsuppression of HIV Infection in the Spanish VACH Cohort.

AIDS research and human retroviruses·2020